Start for free
Start for free
Docor International Management logo

Docor International Management

Asia, Tel Aviv, Israel, Tel Aviv

Description

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the

Investor Profile

Docor International Management has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (22%)
  • Series B (22%)
  • Series Unknown (22%)
  • Debt Financing (11%)
  • Corporate Round (11%)
  • Convertible Note (11%)

Country Focus

  • Israel (78%)
  • United States (22%)

Industry Focus

  • Biotechnology
  • Health Care
  • Manufacturing
  • Nanotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Docor International Management frequently co-invest with?

Catalyst Fund LP
Catalyst Fund LP
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
GE Healthcare
GE Healthcare
North America, Illinois, United States, Chicago
Co-Investments: 1
BXR Partners LLP
BXR Partners LLP
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Fosun Pharma
Fosun Pharma
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Quark Venture
Quark Venture
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
iNetworks 360
iNetworks 360
Asia, Hong Kong Island, Hong Kong, Sheung Wan
Co-Investments: 1
Consolidated Investment Group
Consolidated Investment Group
North America, Colorado, United States, Englewood
Co-Investments: 3
Wille Finance
Wille Finance
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Pontifax
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 4
iVentures Asia
iVentures Asia
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3

Which angels does Docor International Management often collaborate with?

Shmuel Cabilly
Shmuel Cabilly
Asia, HaMerkaz, Israel, Rehovot
Shared Deals: 1
LD
Lord David Alliance
Europe, Manchester, United Kingdom
Shared Deals: 1

What are some of recent deals done by Docor International Management?

Raziel Health

Winter Park, Florida, United States

Raziel Health is a fully integrated health care delivery system, delivered in the comfort and safety of the living room.

Health CareMedicalTherapeutics
Series CDec 18, 2019
Amount Raised: $22,000,000
SP Nano

Yavne, HaMerkaz, Israel

SP Nano is a nanotechnology company commercializing the use of nanoparticles in products made from composite materials.

BiotechnologyManufacturingNanotechnology
Corporate RoundOct 12, 2017
Amount Raised: $2,500,000
SP Nano

Yavne, HaMerkaz, Israel

SP Nano is a nanotechnology company commercializing the use of nanoparticles in products made from composite materials.

BiotechnologyManufacturingNanotechnology
Convertible NoteJun 1, 2015
Amount Raised: $1,200,000
Check-Cap

Isfiyeh, Hefa, Israel

Check-Cap is a young and dynamic medical device company with breakthrough solution for Colorectal Cancer Screening.

BiopharmaBiotechnologyHealth CareMedical Device
Debt FinancingOct 19, 2014
Amount Raised: $12,000,000
SP Nano

Yavne, HaMerkaz, Israel

SP Nano is a nanotechnology company commercializing the use of nanoparticles in products made from composite materials.

BiotechnologyManufacturingNanotechnology
Series BJun 20, 2014
Amount Raised: $2,000,000
Similarweb

New York, New York, United States

SimilarWeb offers an AI-based market intelligence platform that helps monitor web and mobile app traffic.

AnalyticsArtificial Intelligence (AI)Business IntelligenceMarket Research
Series BSep 24, 2013
Amount Raised: $3,500,000
Aposense

Petah Tiqva, HaMerkaz, Israel

Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownAug 20, 2008
Amount Raised: $7,300,000
CritiSense

Givat Haim, HaMerkaz, Israel

CritiSense develops technology for the real-time monitoring of patients' metabolic state and as a novel endpoint of resuscitation.

BiotechnologyHealth Care
Series UnknownJun 21, 2006
Amount Raised: $1,200,000
Protalix BioTherapeutics

Carmiel, HaZafon, Israel

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series CDec 25, 2005
Amount Raised: $5,300,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator